CHASE RANDAL D 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jun 9, 2009
Insider Transaction Report
Form 4
CHASE RANDAL D
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2009-06-05−19,000→ 0 totalFrom: 2009-06-05→ BJCT Common Stock (19,000 underlying) - Exercise/Conversion
BJCT Common Stock
2009-06-05+19,000→ 92,500 total
Footnotes (3)
- [F1]50% vesting per June 5, 2008 Board Grant.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
- [F3]No expiration date.